PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
US Psyc. Author manuscript; available in PMC 2010 July 13.
Published in final edited form as:
US Psyc. 2010 January 1; 3: 39–43.
PMCID: PMC2903064
NIHMSID: NIHMS188054

COMORBIDITY BETWEEN DEPRESSIVE AND ADDICTIVE DISORDERS IN ADOLESCENTS: ROLE OF STRESS AND HPA ACTIVITY

Uma Rao, M.D.

Abstract

Adolescents are at heightened risk for the development of both depressive and addictive disorders. These two disorders frequently co-occur in adolescents and are associated with significant morbidity and mortality. Given the substantial economic and psychosocial burden associated with the comorbid condition, the identification of causal mechanisms associated with their co-occurrence is of great public health importance. Evidence indicates that psychosocial stress contributes to the initiation and maintenance of both depressive and addictive disorders. Research suggests that the limbic-hypothalamic-pituitary-adrenal (LHPA) axis also may be important in the development of depression as well as addictive disorders. Using a diathesis-stress model, this review will examine the interactions between stressful experiences and LHPA axis in increasing the risk for depressive and addictive disorders in adolescents. Emerging evidence suggests that the high rates of comorbidity between these two disorders may be explained, in part, by high levels of stress and altered LHPA activity. Clinical implications of these associations will be discussed.

Keywords: adolescence, addictive disorder, alcohol, cortisol, depression, drug addiction, HPA axis, limbic system, neurobiology, stress, vulnerability

Introduction

Depression is a leading cause of morbidity and mortality in adolescents. Elevated risk for the disorder begins in the early teens and continues to rise in a linear fashion throughout adolescence, with lifetime rates estimated to range from 15% to 25% by late adolescence [13]. Numerous studies also have documented that adolescent depressive episodes persist or recur into adult life along with ongoing psychosocial difficulties [45]. These difficulties include, but are not limited to, disruption in interpersonal relationships, early pregnancy, low educational attainment, poor occupational functioning and unemployment, as well as increased risk for suicidal behavior, resulting in substantial socioeconomic burden [45].

Substance abuse also typically emerges during adolescence [67], and early-onset of substance abuse is associated with a stable and escalating course into adulthood [810]. Depressive and addictive disorders frequently co-occur among adolescents and adults, and when they occur together, adaptive function is compromised further [7, 1113]. The co-occurrence of substance use disorder with depression in adolescents is associated with earlier onset and more severe substance-related problems, increased frequency of behavioral problems, more prolonged and recurrent depressive episodes, and more severe impairment in family, school and legal domains. Youth with the comorbid disorder also are at higher risk for suicidal behavior than those without comorbidity [11, 1314]. As a result, the comorbid illness is associated with increased utilization of health services and substantially higher treatment costs compared with those who have only depression or substance use disorder [15]. Given the economic and psychosocial burden associated with comorbid depressive and addictive disorders, understanding the underlying mechanisms associated with these comorbid conditions is of great public health importance.

Although significant advances have been made with regard to knowledge of the environmental and neurobiological factors involved in depression and substance-related disorders individually, especially in adults, the mechanisms underlying the comorbid illness are not understood well [13, 16]. It is likely that the high prevalence of these disorders occurring together reflects, in part, overlapping genetic, environmental and neurobiological factors. It is also possible that there will be differences in neurobiology based on the temporal course of development of these two disorders; whether depression precedes substance abuse or the reverse. For instance, in the former case, substance use may occur in attempts to improve mood, whereas in the latter it is possible that chronic substance use leads to neurobiological changes that increase vulnerability for depression. The purpose of this paper is to summarize information on overlapping environmental and neurobiological factors, with particular emphasis on psychosocial stress and limbic-hypothalamic-pituitary-adrenal (LHPA) axis. There is a wealth of information on the role of these two factors in association with depression and addictive disorders separately in adult animals and humans, and there is also emerging evidence in adolescent animals and humans.

Contribution of Psychosocial Stress on Vulnerability to Depression

Stress plays a prominent role in most theories of depression, and there is a clear link between stress and depression in children and adolescents [1719]. The relationship between stress and depression appears to be stronger in adolescents than in children, particularly in girls [2022]. The reasons for this are not entirely clear; hormonal effects, consolidation of cognitive styles, cumulative stress burden, and stress reactivity might have a potential role [2223]. One theory proposes that childhood adversity, stemming from abuse, neglect, witnessing domestic violence or house-hold dysfunction, alters neurobiological and psychosocial processes whereby individuals may be sensitized to the effects of recent stressful events, leading to depression at lower levels of stress [24], or with greater physiological reactivity to the effects of stress [2526]; see below for more details on the relationship between environmental stress and LHPA system. Another model suggests that childhood stressors contribute to lifetime stress burden and independently predict depression along with recent stress [2728].

Developmental models of psychopathology also suggest a transactional perspective in which stress-exposure contributes to depressive symptoms and, in turn, depressed individuals contribute to negative events through their own behavior [29]. Longitudinal studies have shown support for the stress-generation model, particularly with regard to interpersonal relationships [2931]. Factors that might contribute to the generation of stress include temperament and personality characteristics [3233], lack of interpersonal competence [30, 34], and comorbid psychopathology [31, 35]. The reciprocal model highlights the “vicious cycle” that can occur between stress and depression, and support for this reciprocal model has been found in a few studies of youngsters [29, 3537].

Although stress clearly plays a role in depression, individuals vary in their response to stress, and how they respond to stress can affect emotional well-being and their future adjustment [17, 38]. Several studies documented interactions between cognitive styles, such as negative attributional style or low perceived self-efficacy, and life stress in the prediction of depression in youngsters [3942]. In addition to the cognitive adaptive styles, other types of coping mechanisms, such as behavioral styles and problem-solving skills, have been examined in relation to depression in youngsters [4344].

Effect of Psychosocial Stress on Vulnerability to Addiction

Stress is also a well-known risk factor in the development of addiction and vulnerability to relapse [4547]. Various hypotheses describe stressors as cues that elicit anticipatory alcohol/drug use responses, as stimuli that evoke negative affective states and prompt substance use to alleviate this emotional distress, or as events that place adaptational demands on an individual [4851].

Preclinical research has indicated that acute exposure to stress enhances self-administration of addictive substances or reinstates drug-seeking behavior in animals with prior exposure [5153]. A series of cross-sectional and longitudinal studies have identified specific stressors as predictors of substance use and abuse among adolescents [5462].

There is substantial evidence for the association between childhood adversity and vulnerability to addictive disorders [56, 63]. Recent trauma and adverse events also increase the risk for substance abuse [5455, 59]. Both distal and proximal events appear to have independent effects on substance abuse, with the impact of cumulative adversity on escalating substance use and addiction occurring in a dose-dependent manner, even after accounting for other variables [58, 61]. Several other factors seem to influence the effect of stress on substance use. For example, the individual’s beliefs about psychoactive substance as a stress-reducing agent, and the available coping resources and social support exert an influence on the consumption of substances during stressful situations [57, 6470]. Also, there are individual differences in stress-reducing effects of drugs which may provide reinforcement for continued use [71]. Inherited characteristics, including temperament/personality traits and variations in the stress-response system, have been attributed to higher reinforcement for drug use and elevated risk for SUD [51, 7173].

The Role of Psychosocial Stress in Comorbid Depressive and Addictive Disorders

Acute as well as chronic stress has been linked with both depressive and addictive disorders [19, 4547]. Chronic stress is a common element of the environmental factors associated with both depression and substance abuse (e.g., low socioeconomic status, family disruption, and dysfunctional interpersonal relationships), and therefore could account for some variance in their co-occurrence [13, 16, 74]. In a recent study of adolescents, higher magnitude of acute stress during prospective follow-up was associated with increased vulnerability to cigarette smoking [75] and substance use disorders [76]. In these reports, acute stress partly accounted for the relationship between depression and addictive disorders. Alternatively, the self-medication model suggests that some individuals use addictive substances to regulate negative affect [67, 77], particularly in the context of stressful situations [78]. The increased prevalence of addictive disorders in individuals with depressive illness [7, 12], and the effect of depression on self-generation of stress [29], raises the question whether psychiatric disorders conceptualized as chronic distress states partly account for the relationship between stress and substance abuse [78]. Additionally, as described below, disruption of the stress–mediated pathways (e.g., the LHPA system) has been documented in relation to both depression and substance abuse, which might serve as a mediator in increasing vulnerability for the comorbid disorder [13, 16, 79].

The LHPA System

The increased vulnerability to depressive episodes and substance abuse under stressful situations may be mediated or moderated by the LHPA system [80]. The LHPA axis is one of the physiological systems that evolved in mammals to help focus and sustain emotional, cognitive, behavioral and metabolic activity in response to conditions of threat [8182]. Upon exposure to stress, neurons in the hypothalamic paraventricular nucleus (PVN) secrete corticotropin-releasing hormone (CRH) which then stimulates the production of adrenocorticotropic hormone (ACTH) from the anterior pituitary. ACTH, in turn, induces the release of glucocorticoids from the adrenal cortex. Several brain circuits modulate the release of these hormones. The amygdala and monoaminergic input from the brainstem stimulate CRH neurons in the PVN, whereas the hippocampus and the prefrontal cortex (PFC; especially the left PFC) send inhibitory signals [83]. Glucocorticoids exert negative feedback on the LHPA axis by regulating hippocampal and PVN neurons. Prolonged glucocorticoid exposure has adverse effects on the hippocampus and PFC, resulting in impaired inhibitory control of the stress pathways [8182].

There are individual differences in the basal activity of the LHPA system and its response to stress, and these differences are regulated by the interaction of genetic and environmental determinants [84]. Studies on the heritability of basal LHPA activity reported that genetic factors accounted for up to 62% of the variance in cortisol levels [85]. Moderate-to-high heritability also has been demonstrated for stress-induced activation of the LHPA axis [86]. Specifically, a twin study observed modest heritability in cortisol responses following the first exposure to a standard psychosocial stressor (h2 < 0.33), and the heritability estimates increased following two additional repetitions of the stressor (h2 > 0.97). These data on the heritability of the LHPA axis has motivated a search for genetic variants in regulating LHPA axis dynamics and vulnerability to psychiatric disorders [84].

Association between LHPA Dysregulation and Depression

Altered LHPA activity is associated with depression, and recent evidence suggests that normalization of the LHPA system might be the final step necessary for stable remission of depressive episodes [87]. There is, however, considerable variability in the degree and direction of LHPA dysfunction in depression [8889]. Recent research has highlighted the importance of experiential factors in explaining the heterogeneity in LHPA dysregulation in depression [9091]. The developing central nervous system is highly sensitive to adverse experiences, and early-life stress leads to increased stress reactivity and alterations in the aforementioned neuronal circuits that persist into adult life. The behavioral effects of sustained CRH at the extra-hypothalamic regions may lead to negative mood, contributing to the development and maintenance of depression [90]. Research indicates, however, that the long-term mood and neurobiological changes associated with early-life stress can be modified by familial/genetic factors and the quality of subsequent environment [25, 9294].

Relationship between LHPA Axis and Addiction

Evidence from preclinical and clinical research suggests that LHPA axis mediates the effects of stress exposure on drug-seeking behavior [4547]. For instance, drug administration stimulates the release of corticotropin-releasing factor (CRF) in the amygdala which, in turn, activates mesocorticolimbic dopamine pathways that are important in the rewarding properties of addictive drugs [9596]. With chronic drug administration, however, mesocorticolimbic dopamine pathways induce a compensatory decrease in CRF receptors [97]; see below for further elaboration of this theme. Other studies indicated that acute withdrawal from addictive substances following chronic administration is associated with elevated LHPA activity [98]. These findings indicate that the LHPA system plays a role in acute as well as withdrawal effects of addictive substances.

Association between LHPA dysregulation and Comorbid Depressive and Addictive Disorders

As described, the LHPA system is involved in both depression and substance abuse. Dysregulation in this system could lead to the comorbid condition in some individuals [13, 99]. In two separate investigations, depressed adolescents who had increased nocturnal cortisol secretion, a period when the LHPA system is normally quiescent, were at increased risk for developing an addictive disorder subsequently compared with their counterparts who had a relatively normal secretory pattern [76, 79]. Also, among adolescents who experimented with alcohol and/or drugs, the progression to addictive disorder was more rapid in the depressed youth compared with non-depressed youngsters [76, 79]. It is possible that the rapid progression to substance abuse in depressed adolescents might result from the addictive drug’s effect in reducing LHPA activity.

Corticosteroids increase self-administration of addictive substances in animals [45, 100]. Reciprocally, addictive substances reduce stress-induced alterations in corticosterone and ACTH and attenuate the anxiogenic effect of CRF in animals [101102]. In humans, alcohol or cocaine consumption has been shown to reduce plasma ACTH and cortisol responses to CRH or to other forms of stress-induction [103104]. An alternative route to the comorbidity in which substance abuse precedes depression also can be explained through the mediating effect of LHPA system. As described previously, chronic drug administration leads to altered CRH neurotransmission [9798]. The deleterious effects of CRH hypersecretion on mood and cognition have been described extensively [80, 87, 105].

It is postulated that the above-described actions of addictive substances on the LHPA system predispose individuals (especially depressed patients with elevated LHPA activity) to initiate alcohol/drug use during stressful situations, finally leading to dependence. Consistent with this hypothesis, in an ongoing study of a group of adolescents with depression and/or nicotine addiction, depressed youth with nicotine addiction had significantly lower LHPA response to a standard psychosocial stressor in the laboratory than their counterparts without smoking history, and also compared to smokers without depression history. Longitudinal assessment of LHPA function in depressed adolescents before and after the development of addictive disorder will be helpful in clarifying whether chronic substance use down-regulates the HPA system in this population.

In the adolescent studies described above, a substantial proportion of the depressed youth with higher nocturnal cortisol secretion also had comorbid anxiety disorder [76, 79]. In contrast to this finding of an association between elevated cortisol and vulnerability to addictive disorders, Moss et al. observed lower cortisol response to an anticipated stressor in pre-adolescent boys whose biological fathers had substance abuse compared with boys whose fathers did not have an addictive disorder [106]. The lower cortisol response during pre-adolescence was associated with “regular” substance use during adolescence [106]. Antisocial disorders mediated the risk for substance-related problems in the “high-risk” group [107]. Other investigators also found that antisocial behaviors/disorders contributed significant variance to the association between depressive and addictive disorders, possibly through common genetic and/or environmental factors shared by all three conditions [108]. These findings suggest that there might be two subgroups of depressed youth at risk for developing addictive disorders, one subgroup with anxiety symptoms and high LHPA function and a second subgroup with conduct symptoms, low LHPA function and high density of substance abuse in family members. It is likely that the two groups would benefit from different treatment strategies.

Clinical Implications and Future Research Directions

If LHPA activity is involved in the pathophysiology of depressive and addictive disorders, this system can be considered as a potential target of intervention for these disorders. Research in animals suggests that the administration of CRF antagonists or anti-glucocorticoid compounds ameliorates anxiety-related symptoms associated with alcohol/drug withdrawal, and also reduces the self-administration of addictive drugs [109112]. Anti-glucocorticoid agents and CRH antagonists appear to have anti-depressant properties, and have been tested in humans for the treatment of depression [113114]. Antidepressant agents also are helpful in reducing substance use, particularly in those with comorbid depression [115116]. However, some individuals with comorbid depressive and addictive disorders show a poor response to antidepressant drugs [116]. The differential response to antidepressant compounds in patients with comorbid depressive and addictive disorder might be related to the LHPA activity.

It is postulated that specifically persons with elevated LHPA activity benefit most from antidepressant agents. Data from clinical and preclinical studies suggest that treatment with antidepressant agents reduces the responsivity to stress [114, 117]. Second, the additional contribution of stressful life experiences in increasing the vulnerability to substance use disorder suggests that such persons might benefit from adjunctive psychosocial interventions [118]. Future studies should evaluate the efficacy of pharmacotherapy and psychosocial interventions, singly and in combination, in patients with depressive and/or addictive disorders stratified on LHPA activity and stress levels.

Acknowledgments

This work was supported, in part, by grants DA14037, DA15131, DA17804, DA17805, MH01419, MH62464 and MH68391 from the National Institutes of Health, and by the Sarah M. and Charles E. Seay Endowed Chair in Child Psychiatry at UT Southwestern Medical Center. The author also would like to express gratitude to Li-Ann Chen, MA, for technical support.

Footnotes

Financial Disclosures: The author does not have any financial conflicts of interest.

References

1. Kessler RC, Aguilar-Gaxiola S, Andrade L, et al. Mental-substance comorbidities in the ICPE surveys. Psychiatria Fennica. 2001;32(suppl 2):62–80.
2. Hankin BL, Abramson LY, Moffitt TE, et al. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol. 1998;107:128–140. [PubMed]
3. Weissman MM, Warner V, Wickramaratne P, et al. Offspring of depressed parents. 10 Years later. Arch Gen Psychiatry. 1997;54:932–940. [PubMed]
4. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry. 1996;35:1575–1583. [PubMed]
5. Rao U, Chen LA. Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialogues Clin Neurosci. 2009;11:45–62. [PMC free article] [PubMed]
6. Giaconia RM, Reinherz HZ, Silverman AB, et al. Ages of onset of psychiatric disorders in a community population of older adolescents. J Am Acad Child Adolesc Psychiatry. 1994;33:706–717. [PubMed]
7. Armstrong TD, Costello EJ. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol. 2002;70:1224–1239. [PubMed]
8. DeWit DJ, Adlaf EM, Offord DR, et al. Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry. 2000;157:745–750. [PubMed]
9. Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1998;10:163–173. [PubMed]
10. Rohde P, Lewinsohn PM, Kahler CW, et al. Natural course of alcohol use disorders from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry. 2001;40:83–90. [PubMed]
11. Davis L, Uezato A, Newell JM, et al. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008;21:14–18. [PubMed]
12. Kuo PH, Gardner CO, Kendler KS, et al. The temporal relationship of the onsets of alcohol dependence and major depression: using a genetically informative study design. Psychol Med. 2006;36:1153–1162. [PubMed]
13. Rao U, Chen L. Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Current Drug Abuse Reviews. 2008;1:68–80. [PubMed]
14. Deas D, Thomas S. Comorbid Pyschiatric Factors Contributing to Adolescent Alcohol and Other Drug Use. Alcohol Research & Health. 2002;26:116–121.
15. King RD, Gaines LS, Lambert EW, et al. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417–430. [PubMed]
16. Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry. 2004;56:714–717. [PubMed]
17. Garber J. Depression in children and adolescents: linking risk research and prevention. Am J Prev Med. 2006;31:S104–125. [PubMed]
18. Grant KE, Compas BE, Thurm AE, et al. Stressors and child and adolescent psychopathology: measurement issues and prospective effects. J Clin Child Adolesc Psychol. 2004;33:412–425. [PubMed]
19. Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319. [PubMed]
20. Ge X, Lorenz FO, Conger RD, et al. Trajectories of Stressful Life Events and Depressive Symptoms During Adolescence. Developmental Psychology. 1994;30:467–483.
21. Larson R, Ham M. Stress and Storm and Stress in Early Adolescence - the Relationship of Negative Events with Dysphoric Affect. Developmental Psychology. 1993;29:130–140.
22. Rudolph KD, Hammen C. Age and gender as determinants of stress exposure, generation, and reactions in youngsters: a transactional perspective. Child Dev. 1999;70:660–677. [PubMed]
23. Zahn-Waxler C, Shirtcliff EA, Marceau K. Disorders of childhood and adolescence: gender and psychopathology. Annu Rev Clin Psychol. 2008;4:275–303. [PubMed]
24. Hammen C, Henry R, Daley SE. Depression and sensitization to stressors among young women as a function of childhood adversity. J Consult Clin Psychol. 2000;68:782–787. [PubMed]
25. Heim C, Newport DJ, Wagner D, et al. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety. 2002;15:117–125. [PubMed]
26. Rao U, Hammen C, Ortiz LR, et al. Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents. Biol Psychiatry. 2008;64:521–526. [PMC free article] [PubMed]
27. Turner RJ, Lloyd DA. Lifetime traumas and mental health: the significance of cumulative adversity. J Health Soc Behav. 1995;36:360–376. [PubMed]
28. Hazel NA, Hammen C, Brennan PA, et al. Early childhood adversity and adolescent depression: the mediating role of continued stress. Psychol Med. 2008;38:581–589. [PubMed]
29. Hammen C. Stress generation in depression: reflections on origins, research, and future directions. J Clin Psychol. 2006;62:1065–1082. [PubMed]
30. Davila J, Hammen C, Burge D, et al. Poor interpersonal problem solving as a mechanism of stress generation in depression among adolescent women. J Abnorm Psychol. 1995;104:592–600. [PubMed]
31. Rudolph KD, Hammen C, Burge D, et al. Toward an interpersonal life-stress model of depression: the developmental context of stress generation. Dev Psychopathol. 2000;12:215–234. [PubMed]
32. Daley SE, Hammen C, Davila J, et al. Axis II symptomatology, depression, and life stress during the transition from adolescence to adulthood. J Consult Clin Psychol. 1998;66:595–603. [PubMed]
33. Nelson DR, Hammen C, Daley SE, et al. Sociotropic and autonomous personality styles: Contributions to chronic life stress. Cognitive Therapy and Research. 2001;25:61–76.
34. Herzberg DS, Hammen C, Burge D, et al. Social competence as a predictor of chronic interpersonal stress. Personal Relationships. 1998;5:207–218.
35. Daley SE, Hammen C, Burge D, et al. Predictors of the generation of episodic stress: a longitudinal study of late adolescent women. J Abnorm Psychol. 1997;106:251–259. [PubMed]
36. Cohen LH, Burt CE, Bjorck JP. Life Stress and Adjustment - Effects of Life Events Experienced by Young Adolescents and Their Parents. Developmental Psychology. 1987;23:583–592.
37. Kim KJ, Conger RD, Elder GH, Jr, et al. Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Dev. 2003;74:127–143. [PubMed]
38. Compas BE, Connor-Smith J, Jaser SS. Temperament, stress reactivity, and coping:implications for depression in childhood and adolescence. J Clin Child Adolesc Psychol. 2004;33:21–31. [PubMed]
39. Hankin BL, Abramson LY. Development of gender differences in depression: an elaborated cognitive vulnerability-transactional stress theory. Psychol Bull. 2001;127:773–796. [PubMed]
40. Hilsman R, Garber J. A test of the cognitive diathesis-stress model of depression in children: academic stressors, attributional style, perceived competence, and control. J Pers Soc Psychol. 1995;69:370–380. [PubMed]
41. Lewinsohn PM, Joiner TE, Jr, Rohde P. Evaluation of cognitive diathesis-stress models in predicting major depressive disorder in adolescents. J Abnorm Psychol. 2001;110:203–215. [PubMed]
42. Robinson NS, Garber J, Hilsman R. Cognitions and stress: direct and moderating effects on depressive versus externalizing symptoms during the junior high school transition. J Abnorm Psychol. 1995;104:453–463. [PubMed]
43. Compas BE, Connor-Smith JK, Saltzman H, et al. Coping with stress during childhood and adolescence: problems, progress, and potential in theory and research. Psychol Bull. 2001;127:87–127. [PubMed]
44. Lazarus R, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
45. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007;164:1149–1159. [PMC free article] [PubMed]
46. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008;1141:105–130. [PMC free article] [PubMed]
47. Uhart M, Wand GS. Stress, alcohol and drug interaction: an update of human research. Addict Biol. 2009;14:43–64. [PMC free article] [PubMed]
48. Baker TB, Piper ME, McCarthy DE, et al. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111:33–51. [PubMed]
49. Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction. 1999;94:327–340. [PubMed]
50. Pohorecky LA. Stress and alcohol interaction: an update of human research. Alcohol Clin Exp Res. 1991;15:438–459. [PubMed]
51. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001;158:343–359. [PubMed]
52. Breese GR, Chu K, Dayas CV, et al. Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res. 2005;29:185–195. [PMC free article] [PubMed]
53. Cleck JN, Blendy JA. Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest. 2008;118:454–461. [PMC free article] [PubMed]
54. Barrett AE, Turner RJ. Family structure and substance use problems in adolescence and early adulthood: examining explanations for the relationship. Addiction. 2006;101:109–120. [PubMed]
55. Clark DB, Lesnick L, Hegedus AM. Traumas and other adverse life events in adolescents with alcohol abuse and dependence. J Am Acad Child Adolesc Psychiatry. 1997;36:1744–1751. [PubMed]
56. Dube SR, Felitti VJ, Dong M, et al. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111:564–572. [PubMed]
57. Fishbein DH, Herman-Stahl M, Eldreth D, et al. Mediators of the stress-substance-use relationship in urban male adolescents. Prev Sci. 2006;7:113–126. [PubMed]
58. Lloyd DA, Turner RJ. Cumulative lifetime adversities and alcohol dependence in adolescence and young adulthood. Drug Alcohol Depend. 2008;93:217–226. [PMC free article] [PubMed]
59. Newcomb MD, Harlow LL. Life events and substance use among adolescents: mediating effects of perceived loss of control and meaninglessness in life. J Pers Soc Psychol. 1986;51:564–577. [PubMed]
60. Sher KJ, Gershuny BS, Peterson L, et al. The role of childhood stressors in the intergenerational transmission of alcohol use disorders. J Stud Alcohol. 1997;58:414–427. [PubMed]
61. Turner RJ, Lloyd DA. Cumulative adversity and drug dependence in young adults: racial/ethnic contrasts. Addiction. 2003;98:305–315. [PubMed]
62. Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol. 2004;16:1007–1027. [PubMed]
63. Dunn MG, Tarter RE, Mezzich AC, et al. Origins and consequences of child neglect in substance abuse families. Clin Psychol Rev. 2002;22:1063–1090. [PubMed]
64. Brown SA, Stetson BA, Beatty PA. Cognitive and behavioral features of adolescent coping in high-risk drinking situations. Addict Behav. 1989;14:43–52. [PubMed]
65. Kuntsche E, Knibbe R, Gmel G, et al. Why do young people drink? A review of drinking motives. Clin Psychol Rev. 2005;25:841–861. [PubMed]
66. Litman GK, Stapleton J, Oppenheim AN, et al. The relationship between coping behaviours, their effectiveness and alcoholism relapse and survival. Br J Addict. 1984;79:283–291. [PubMed]
67. Measelle JR, Stice E, Springer DW. A prospective test of the negative affect model of substance abuse: moderating effects of social support. Psychol Addict Behav. 2006;20:225–233. [PMC free article] [PubMed]
68. Peirce RS, Frone MR, Russell M, et al. A longitudinal model of social contact, social support, depression, and alcohol use. Health Psychol. 2000;19:28–38. [PubMed]
69. Wills TA, Cleary SD. Stress-Coping Model for Alcohol/Tobacco Interactions in Adolescence. In: Fertig J, Allen J, editors. Alcohol and Tobacco: From Basic Science to Policy. Bethesda, MD: Department of Health and Human Services, National Institute on Alcohol Abuse and Alcoholism; 1995. pp. 107–128.
70. Wills TA, Cleary SD. How are social support effects mediated? A test with parental support and adolescent substance use. J Pers Soc Psychol. 1996;71:937–952. [PubMed]
71. Sher KJ, Levenson RW. Risk for alcoholism and individual differences in the stress-response-dampening effect of alcohol. J Abnorm Psychol. 1982;91:350–367. [PubMed]
72. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573–588. [PubMed]
73. Saraceno L, Munafo M, Heron J, et al. Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: a review. Addiction. 2009;104:1100–1121. [PubMed]
74. Kendler KS, Prescott CA, Myers J, et al. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937. [PubMed]
75. Rao U, Hammen CL, London ED, et al. Contribution of Hypothalamic-Pituitary-Adrenal Activity and Environmental Stress to Vulnerability for Smoking in Adolescents. Neuropsychopharmacology. 2009;34(13):2721–2732. [PMC free article] [PubMed]
76. Rao U, Hammen CL, Poland RE. Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity. Am J Psychiatry. 2009;166:361–369. [PMC free article] [PubMed]
77. Sher KJ, Walitzer KS, Wood PK, et al. Characteristics of children of alcoholics: putative risk factors, substance use and abuse, and psychopathology. J Abnorm Psychol. 1991;100:427–448. [PubMed]
78. Peirce RS, Frone MR, Russell M, et al. Relationship of financial strain and psychosocial resources to alcohol use and abuse: the mediating role of negative affect and drinking motives. J Health Soc Behav. 1994;35:291–308. [PubMed]
79. Rao U, Ryan ND, Dahl RE, et al. Factors associated with the development of substance use disorder in depressed adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:1109–1117. [PubMed]
80. De Kloet ER. Hormones and the stressed brain. Ann N Y Acad Sci. 2004;1018:1–15. [PubMed]
81. Lopez JF, Akil H, Watson SJ. Neural circuits mediating stress. Biol Psychiatry. 1999;46:1461–1471. [PubMed]
82. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032:1–7. [PubMed]
83. Sullivan RM, Gratton A. Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters. Psychoneuroendocrinology. 2002;27:99–114. [PubMed]
84. Gillespie CF, Phifer J, Bradley B, et al. Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety. 2009;26:984–992. [PMC free article] [PubMed]
85. Bartels M, Van den Berg M, Sluyter F, et al. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology. 2003;28:121–137. [PubMed]
86. Federenko IS, Nagamine M, Hellhammer DH, et al. The heritability of hypothalamus pituitary adrenal axis responses to psychosocial stress is context dependent. J Clin Endocrinol Metab. 2004;89:6244–6250. [PubMed]
87. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord. 2001;62:77–91. [PubMed]
88. Burke HM, Davis MC, Otte C, et al. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology. 2005;30:846–856. [PubMed]
89. Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendocrinology. 2009;34:1272–1283. [PMC free article] [PubMed]
90. Heim C, Plotsky PM, Nemeroff CB. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology. 2004;29:641–648. [PubMed]
91. Kaufman J, Charney D. Effects of early stress on brain structure and function: implications for understanding the relationship between child maltreatment and depression. Dev Psychopathol. 2001;13:451–471. [PubMed]
92. Bradley RG, Binder EB, Epstein MP, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry. 2008;65:190–200. [PMC free article] [PubMed]
93. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389. [PubMed]
94. Kaufman J, Yang BZ, Douglas-Palumberi H, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A. 2004;101:17316–17321. [PubMed]
95. Barrot M, Marinelli M, Abrous DN, et al. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci. 2000;12:973–979. [PubMed]
96. Funk CK, O’Dell LE, Crawford EF, et al. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci. 2006;26:11324–11332. [PubMed]
97. Goeders NE, Bienvenu OJ, De Souza EB. Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res. 1990;531:322–328. [PubMed]
98. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci. 2000;25:125–136. [PMC free article] [PubMed]
99. Bruijnzeel AW, Repetto M, Gold MS. Neurobiological mechanisms in addictive and psychiatric disorders. Psychiatr Clin North Am. 2004;27:661–674. [PubMed]
100. Piazza PV, Le Moal M. The role of stress in drug self-administration. Trends Pharmacol Sci. 1998;19:67–74. [PubMed]
101. Thatcher-Britton K, Koob GF. Alcohol reverses the proconflict effect of corticotropin-releasing factor. Regul Pept. 1986;16:315–320. [PubMed]
102. Rivier C, Imaki T, Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Res. 1990;520:1–5. [PubMed]
103. Goeders NE. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology. 1997;22:237–259. [PubMed]
104. Waltman C, Blevins LS, Jr, Boyd G, et al. The effects of mild ethanol intoxication on the hypothalamic-pituitary-adrenal axis in nonalcoholic men. J Clin Endocrinol Metab. 1993;77:518–522. [PubMed]
105. Zobel AW, Schulze-Rauschenbach S, von Widdern OC, et al. Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. J Psychiatr Res. 2004;38:377–383. [PubMed]
106. Moss HB, Vanyukov M, Yao JK, et al. Salivary cortisol responses in prepubertal boys: the effects of parental substance abuse and association with drug use behavior during adolescence. Biol Psychiatry. 1999;45:1293–1299. [PubMed]
107. Clark DB, Parker AM, Lynch KG. Psychopathology and substance-related problems during early adolescence: a survival analysis. J Clin Child Psychol. 1999;28:333–341. [PubMed]
108. Fu Q, Heath AC, Bucholz KK, et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry. 2002;59:1125–1132. [PubMed]
109. Fahlke C, Hard E, Thomasson R, et al. Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav. 1994;48:977–981. [PubMed]
110. Heinrichs SC, Menzaghi F, Schulteis G, et al. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol. 1995;6:74–80. [PubMed]
111. Piazza PV, Marinelli M, Jodogne C, et al. Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 1994;658:259–264. [PubMed]
112. Rassnick S, Heinrichs SC, Britton KT, et al. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993;605:25–32. [PubMed]
113. Gallagher P, Malik N, Newham J, et al. Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev. 2008:CD005168. [PubMed]
114. Holsboer F, Ising M. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol. 2008;583:350–357. [PubMed]
115. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry. 2004;56:793–802. [PubMed]
116. Torrens M, Fonseca F, Mateu G, et al. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend. 2005;78:1–22. [PubMed]
117. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999;46:1181–1191. [PubMed]
118. Manber R, Kraemer HC, Arnow BA, et al. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. J Consult Clin Psychol. 2008;76:459–467. [PubMed]